Bicycle Therapeutics Appoints Travis Thompson as New Chief Financial Officer

summarizeSummary

Bicycle Therapeutics announced the appointment of Travis Thompson, previously SVP and Chief Accounting Officer, as its new Chief Financial Officer, succeeding Alethia Young in a planned transition.

check_boxKey Events

• New Chief Financial Officer Appointed

  Travis Thompson, previously the company's Senior Vice President and Chief Accounting Officer since June 2023, has been appointed as the new Chief Financial Officer, effective January 29, 2026.

• Outgoing CFO Transition and Advisory Role

  Alethia Young transitioned from her CFO role and will remain with the company in an interim capacity for three months, followed by a two-year advisory role under a consulting agreement.

• New CFO Compensation Details

  Mr. Thompson's employment agreement includes a base salary of $500,000, a target annual cash performance bonus of 50% of his base salary, and an option to purchase 58,000 ordinary shares.

auto_awesomeAnalysis

The appointment of Travis Thompson as Chief Financial Officer represents a key leadership transition for Bicycle Therapeutics. His internal promotion from Senior Vice President and Chief Accounting Officer, coupled with his long tenure at the company and prior experience in biotech finance, suggests a focus on continuity and stability in financial operations. The smooth transition with outgoing CFO Alethia Young, who will serve in an interim and advisory capacity, further mitigates potential disruption. This change is important for maintaining strong financial leadership as the company continues to advance its clinical pipeline.